Lemaitre Vascular (LMAT) Gross Profit (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Gross Profit data on file, last reported at $48.4 million in Q1 2026.

• Quarterly Gross Profit rose 16.84% year-over-year to $48.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185.5 million (up 19.18% YoY) and the FY2025 annual result came in at $178.5 million, up 18.32% from the prior year.
• Gross Profit rose to $48.4 million in Q1 2026 per LMAT's latest filing, from $46.2 million in the prior quarter.
• Across five years, Gross Profit topped out at $48.4 million in Q1 2026 and bottomed at $25.1 million in Q3 2022.
• The 5-year median for Gross Profit is $36.7 million (2024), against an average of $35.9 million.
• The widest annual swing landed in 2022, when Gross Profit climbed 0.38%; it then rose 27.68% in 2023.
• Tracing LMAT's Gross Profit over 5 years: stood at $26.1 million in 2022, then climbed by 27.68% to $33.3 million in 2023, then increased by 16.01% to $38.6 million in 2024, then gained by 19.69% to $46.2 million in 2025, then increased by 4.78% to $48.4 million in 2026.
• Per Business Quant, the three latest LMAT Gross Profit figures stand at $48.4 million (Q1 2026), $46.2 million (Q4 2025), and $46.0 million (Q3 2025).

Peer Comparison